Seya Industries Limited (SEYAIND) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.011x

Based on the latest financial reports, Seya Industries Limited (SEYAIND) has a cash flow conversion efficiency ratio of -0.011x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-92.31 Million ≈ $-998.24K USD) by net assets (Rs8.20 Billion ≈ $88.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Seya Industries Limited balance sheet independence to measure how much of total assets are equity-financed.

Seya Industries Limited - Cash Flow Conversion Efficiency Trend (2011–2026)

This chart illustrates how Seya Industries Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Seya Industries Limited cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Seya Industries Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Seya Industries Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Jiangsu Huasheng Tianlong Photo
SHE:300029
0.320x
Xiwang Property Holdings Company Limited
F:XSA
0.000x
Willings Co. Ltd
KQ:313760
0.010x
B90 HOLDINGS PLC
F:24GN
N/A
The Scottish Oriental Smaller Companies Trust plc
LSE:SST
0.012x
CPU Softwarehouse AG
F:CPU2
-0.015x
Octopus Titan VCT
LSE:OTV2
-0.015x
KOYJ Co. Ltd
KQ:121850
-1.361x

Annual Cash Flow Conversion Efficiency for Seya Industries Limited (2011–2026)

The table below shows the annual cash flow conversion efficiency of Seya Industries Limited from 2011 to 2026. For the full company profile with market capitalisation and key ratios, see SEYAIND company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs8.18 Billion
≈ $88.51 Million
Rs-166.58 Million
≈ $-1.80 Million
-0.020x +2.17%
2025-03-31 Rs8.21 Billion
≈ $88.82 Million
Rs-170.87 Million
≈ $-1.85 Million
-0.021x -63.91%
2024-03-31 Rs8.28 Billion
≈ $89.51 Million
Rs-105.05 Million
≈ $-1.14 Million
-0.013x +17.38%
2023-03-31 Rs8.31 Billion
≈ $89.88 Million
Rs-127.67 Million
≈ $-1.38 Million
-0.015x -208.42%
2022-03-31 Rs8.56 Billion
≈ $92.55 Million
Rs121.26 Million
≈ $1.31 Million
0.014x +235.34%
2021-03-31 Rs8.62 Billion
≈ $93.23 Million
Rs-90.25 Million
≈ $-976.06K
-0.010x -688.17%
2020-03-31 Rs9.72 Billion
≈ $105.08 Million
Rs17.30 Million
≈ $187.05K
0.002x -98.25%
2019-03-31 Rs9.29 Billion
≈ $100.47 Million
Rs946.04 Million
≈ $10.23 Million
0.102x +2.28%
2018-03-31 Rs7.40 Billion
≈ $80.06 Million
Rs737.09 Million
≈ $7.97 Million
0.100x -25.17%
2017-03-31 Rs5.18 Billion
≈ $56.00 Million
Rs689.02 Million
≈ $7.45 Million
0.133x +105.51%
2016-03-31 Rs2.40 Billion
≈ $25.99 Million
Rs155.61 Million
≈ $1.68 Million
0.065x +2.64%
2015-03-31 Rs2.16 Billion
≈ $23.40 Million
Rs136.51 Million
≈ $1.48 Million
0.063x +537.42%
2014-03-31 Rs2.03 Billion
≈ $21.99 Million
Rs20.13 Million
≈ $217.66K
0.010x -87.70%
2013-03-31 Rs487.57 Million
≈ $5.27 Million
Rs39.23 Million
≈ $424.23K
0.080x -97.25%
2012-03-31 Rs469.40 Million
≈ $5.08 Million
Rs1.37 Billion
≈ $14.87 Million
2.929x +1788.53%
2011-03-31 Rs460.64 Million
≈ $4.98 Million
Rs71.44 Million
≈ $772.59K
0.155x --

About Seya Industries Limited

NSE:SEYAIND India Specialty Chemicals
Market Cap
$3.52 Million
Rs325.49 Million INR
Market Cap Rank
#29178 Global
#1624 in India
Share Price
Rs12.25
Change (1 day)
-0.81%
52-Week Range
Rs8.71 - Rs23.99
All Time High
Rs462.48
About

Seya Industries Limited manufactures and sells specialty chemicals in India and internationally. The company offers pigment intermediates, such as 3,3 dichloro benzidine, and para and ortho nitro aniline; mono, para, and ortho chloro benzenes; para, ortho, meta, and 2,4 nitro chloro benzenes; and sulphuric, hydrochloric, and nitric acids. Its products are used in pharmaceuticals, personal and hea… Read more